Increased incidence of non-Hodgkin’s lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low. - Farrell,R.J.; Ang,Y.; Kileen,P.; O’Briain,D.SO.; Kelleher,D.; Keeling,P.W. (Gut, 2000)